Connection

Philip Privitera to Dogs

This is a "connection" page, showing publications Philip Privitera has written about Dogs.
Connection Strength

0.128
  1. Afferent vagal stimulation, vasopressin, and nitroprusside alter cerebrospinal fluid kinin. Am J Physiol. 1987 Jul; 253(1 Pt 2):R136-41.
    View in: PubMed
    Score: 0.016
  2. Site and mechanism of the centrally mediated hypotensive action of propranolol. J Pharmacol Exp Ther. 1985 Oct; 235(1):66-70.
    View in: PubMed
    Score: 0.014
  3. Cerebrospinal fluid kinins and cardiovascular function. Effects of cerebroventricular melittin. Hypertension. 1984 Mar-Apr; 6(2 Pt 2):I46-50.
    View in: PubMed
    Score: 0.013
  4. Persistence of myocardial failure following removal of chronic volume overload. Am J Physiol. 1982 Dec; 243(6):H876-83.
    View in: PubMed
    Score: 0.012
  5. Nicotinic-like effects and tissue disposition of isopropylamine. J Pharmacol Exp Ther. 1982 Jul; 222(1):116-21.
    View in: PubMed
    Score: 0.011
  6. Cerebroventricular propranolol elevates cerebrospinal fluid norepinephrine and lowers blood pressure. Science. 1981 Aug 21; 213(4510):911-3.
    View in: PubMed
    Score: 0.011
  7. Effects of centrally administered propranolol on plasma renin activity, plasma norepinephrine and arterial pressure. Eur J Pharmacol. 1979 Feb 15; 54(1-2):51-60.
    View in: PubMed
    Score: 0.009
  8. Studies of the interrelationship between plasma norepinephrine, plasma renin activity and acute myocardial infarction in dogs. Res Commun Chem Pathol Pharmacol. 1978 May; 20(2):289-302.
    View in: PubMed
    Score: 0.009
  9. Adrenergic blocking and cardiovascular effects of a new N-substituted tetrahydroisoquinoline (NC 7197). J Pharmacol Exp Ther. 1971 Mar; 176(3):655-61.
    View in: PubMed
    Score: 0.005
  10. A comparison of the cardiovascular effects of biogenic amines and their precursors in newborn and adult dogs. J Pharmacol Exp Ther. 1969 Apr; 166(2):293-8.
    View in: PubMed
    Score: 0.005
  11. Stereochemistry of tissue distribution of racemic propranolol in the dog. Chirality. 1989; 1(3):192-6.
    View in: PubMed
    Score: 0.004
  12. Cardiovascular and myocardial metabolic effects of infusions of phenylephrine. J Pharmacol Exp Ther. 1967 May; 156(2):325-30.
    View in: PubMed
    Score: 0.004
  13. Adrenergic nerve stimulation-induced release of propranolol from the perfused hindlimb and spleen of the dog and associated changes in postjunctional response. J Pharmacol Exp Ther. 1983 Aug; 226(2):324-9.
    View in: PubMed
    Score: 0.003
  14. Furosemide increases urine 6-keto-prostaglandin F1 alpha. Relation to natriuresis, vasodilation, and renin release. Hypertension. 1982 Sep-Oct; 4(5):634-41.
    View in: PubMed
    Score: 0.003
  15. Cardiovascular effects of a 4'-methylthio analog of propranolol. J Pharmacol Exp Ther. 1981 Dec; 219(3):685-90.
    View in: PubMed
    Score: 0.003
  16. Effects of perhexiline on survival time and infarct size in experimental myocardial infarction. J Pharmacol Exp Ther. 1977 Jan; 200(1):155-65.
    View in: PubMed
    Score: 0.002
  17. Cardiovascular actions of a new metabolite of propranolol: isopropylamine. J Pharmacol Exp Ther. 1974 Jun; 189(3):626-32.
    View in: PubMed
    Score: 0.002
  18. Hemodynamic effects of phenoxybenzamine in anesthetized dogs. J Clin Invest. 1970 Nov; 49(11):2036-50.
    View in: PubMed
    Score: 0.001
  19. Effects of hydrocortisone on survival in neonatal beagles given endotoxin. Proc Soc Exp Biol Med. 1968 May; 128(1):326-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.